Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
3
×
deals
3
×
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
3
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
cancer
diagnostics
eli lilly
What
bio
drug
roundup
companies
price
acquisitions
albert
alzheimer’s
approval
biggest
biogen’s
biopharmaceutical
bourla
ceo
company
convo
crispr
different
earlier
fail
failures
future
gene
imports
increases
latest
littered
maker
maps
measured
nash
new
news
patients
pfizer
pfizer’s
pharmaceutical
plan
prescription
prices
Language
unknown
Current search:
medicare
×
startups
×
" san diego blog main "
×
deals
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More